{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:02:37Z","timestamp":1784044957232,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["Merit Review Grant"],"award-info":[{"award-number":["Merit Review Grant"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS44687"],"award-info":[{"award-number":["NS44687"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA137488"],"award-info":[{"award-number":["CA137488"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007155","name":"Walter S. and Lucienne Driskill Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11060-015-2000-1","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T09:02:09Z","timestamp":1449046929000},"page":"447-454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Intra-arterial administration improves temozolomide delivery and efficacy in a model of intracerebral metastasis, but has unexpected brain toxicity"],"prefix":"10.1007","volume":"126","author":[{"given":"Leslie L.","family":"Muldoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Pagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao Prola","family":"Netto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Neuwelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,2]]},"reference":[{"key":"2000_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross J, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"key":"2000_CR2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1148\/radiol.12111472","volume":"266","author":"S Gahramanov","year":"2013","unstructured":"Gahramanov S, Muldoon LL, Varallyay CG, Li X, Kraemer DF, Fu R, Hamilton BE, Rooney WD, Neuwelt EA (2013) Pseudoprogression of glioblastoma after chemo- and radiation therapy: diagnosis by using dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging with ferumoxytol versus gadoteridol and correlation with survival. Radiology 266:842\u2013852. doi:\n                    10.1148\/radiol.12111472","journal-title":"Radiology"},{"key":"2000_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S0093-7754(01)90069-7","volume":"28","author":"LE Abrey","year":"2001","unstructured":"Abrey LE, Christodoulou C (2001) Temozolomide for treating brain metastases. Seminars Oncol 28:34\u201342","journal-title":"Seminars Oncol"},{"key":"2000_CR4","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1007\/s12094-014-1190-x","volume":"16","author":"Q Wang","year":"2014","unstructured":"Wang Q, Jiang Z, Qi X, Lu S, Wang S, Leng C, Lu F, Liu HL, Liang S, Shi J (2014) Whole brain radiation therapy followed by intensity-modulated boosting treatment combined with concomitant temozolomide for brain metastases from non-small-cell lung cancer. Clin Transl Oncol 16:1000\u20131005","journal-title":"Clin Transl Oncol"},{"key":"2000_CR5","doi-asserted-by":"publisher","first-page":"7092","DOI":"10.1158\/1078-0432.CCR-09-1349","volume":"15","author":"J Portnow","year":"2009","unstructured":"Portnow J, Badie B, Chen M, Liu A, Blanchard S, Synold TW (2009) The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation. Clin Cancer Res 15:7092\u20137098","journal-title":"Clin Cancer Res"},{"key":"2000_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00280-012-1867-1","volume":"70","author":"R Grossman","year":"2012","unstructured":"Grossman R, Rudek MA, Brastianos H, Zadnik P, Brem H, Tyler B, Blakeley JO (2012) The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas. Cancer Chemother Pharmacol 70:129\u2013139","journal-title":"Cancer Chemother Pharmacol"},{"key":"2000_CR7","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1200\/JCO.2006.09.9861","volume":"25","author":"LL Muldoon","year":"2007","unstructured":"Muldoon LL, Soussain C, Jahnke K, Johanson C, Siegal T, Smith QR, Hall W, Hynynen K, Senter P, Peereboom DM, Neuwelt EA (2007) Chemotherapy delivery issues in central nervous system malignancy: a reality check. J Clinical Oncol 25:2295\u20132305","journal-title":"J Clinical Oncol"},{"key":"2000_CR8","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.3171\/2014.12.FOCUS14758","volume":"38","author":"TD Azad","year":"2015","unstructured":"Azad TD, Pan J, Connolly ID, Remington A, Wilson CM, Grant GA (2015) Therapeutic strategies to improve drug delivery across the blood\u2013brain barrier. Neurosurg Focus 38:E9","journal-title":"Neurosurg Focus"},{"key":"2000_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3109\/02688697.2013.877122","volume":"28","author":"C Theodotou","year":"2014","unstructured":"Theodotou C, Shah AH, Hayes S, Bregy A, Johnson JN, Aziz-Sultan MA, Komotar RJ (2014) The role of intra-arterial chemotherapy as an adjuvant treatment for glioblastoma. Br J Neurosurg 28:438\u2013446","journal-title":"Br J Neurosurg"},{"key":"2000_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<637::AID-CNCR22>3.0.CO;2-Y","volume":"88","author":"ND Doolittle","year":"2000","unstructured":"Doolittle ND, Miner ME, Hall WA, Siegal T, Hanson EJ, Osztie E, McAllister LD, Bubalo JS, Kraemer DF, Fortin D, Nixon R, Muldoon LL, Neuwelt EA (2000) Safety and efficacy of a multi-center study using intraarterial chemotherapy in conjunction with osmotic opening of the blood\u2013brain barrier for the treatment of malignant brain tumors. Cancer 88:637\u2013647","journal-title":"Cancer"},{"key":"2000_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/bs.apha.2014.06.002","volume":"71","author":"ND Doolittle","year":"2014","unstructured":"Doolittle ND, Muldoon LL, Culp AY, Neuwelt EA (2014) Delivery of chemotherapeutics across the blood\u2013brain barrier: challenges and advances. Adv Pharmacol 71:203\u2013243. doi:\n                    10.1016\/bs.apha.2014.06.002","journal-title":"Adv Pharmacol"},{"key":"2000_CR12","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1200\/JCO.2008.19.3789","volume":"27","author":"L Angelov","year":"2009","unstructured":"Angelov L, Doolittle ND, Kraemer DF, Siegal T, Barnett GH, Peereboom DM, Stevens G, McGergor J, Jahnke K, Lacy CA, Hedrick NA, Shalom E, Ference S, Bell S, Sorenson L, Tyson RM, Haluska M, Neuwelt EA (2009) Blood\u2013brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience. J Clinical Oncol 27:3503\u20133509","journal-title":"J Clinical Oncol"},{"key":"2000_CR13","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1124\/jpet.103.063347","volume":"309","author":"EA Neuwelt","year":"2004","unstructured":"Neuwelt EA, Pagel MA, Kraemer DF, Peterson DR, Muldoon LL (2004) Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model. J Pharmacol Exp Ther 309:594\u2013599","journal-title":"J Pharmacol Exp Ther"},{"key":"2000_CR14","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3171\/jns.1997.86.3.0525","volume":"86","author":"DL Silbergeld","year":"1997","unstructured":"Silbergeld DL, Chicoine MR (1997) Isolation and characterization of human malignant glioma cells from histologically normal brain. J Neurosurg Pediatr 86:525\u2013531","journal-title":"J Neurosurg Pediatr"},{"key":"2000_CR15","first-page":"553","volume":"26","author":"F Imbesi","year":"2006","unstructured":"Imbesi F, Marchioni E, Benericetti E, Zappoli F, Galli A, Corato M, Ceroni M (2006) A randomized phase III study: comparison between intravenous and intraarterial ACNU administration in newly diagnosed primary glioblastomas. Anticancer Res 26:553\u2013558","journal-title":"Anticancer Res"},{"key":"2000_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1215\/15228517-2008-088","volume":"11","author":"Q Zhou","year":"2009","unstructured":"Zhou Q, Gallo JM (2009) Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model. Neuro Oncol 11:301\u2013310","journal-title":"Neuro Oncol"},{"key":"2000_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1212\/WNL.0b013e318297eeba","volume":"81","author":"ND Doolittle","year":"2013","unstructured":"Doolittle ND, Korfel A, Lubow MA, Schorb E, Schlegel U, Rogowski S, Fu R, Dosa E, Illerhaus G, Kraemer DF, Muldoon LL, Calabrese P, Hedrick NA, Tyson RM, Jahnke K, Maron LM, Butler RW, Neuwelt EA (2013) Long-term cognitive function, neuroimaging, and quality of life in primary CNS lymphoma. Neurology 81:84\u201392. doi:\n                    10.1212\/WNL.0b013e318297eeba","journal-title":"Neurology"},{"key":"2000_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s11060-014-1504-4","volume":"119","author":"D Fortin","year":"2014","unstructured":"Fortin D, Morin PA, Belzile F, Mathieu D, Par\u00e9 FM (2014) Intra-arterial carboplatin as a salvage strategy in the treatment of recurrent glioblastoma multiforme. J Neurooncol 119:397\u2013403","journal-title":"J Neurooncol"},{"key":"2000_CR19","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1593\/neo.08928","volume":"10","author":"V Mathieu","year":"2008","unstructured":"Mathieu V, De Neve N, Le Mercier M, Dewelle J, Gaussin JF, Dehoux M, Kiss R, Lefranc F (2008) Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model. Neoplasia 10:1383\u20131392","journal-title":"Neoplasia"},{"key":"2000_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2045-8118-12-5","volume":"12","author":"GL Pishko","year":"2015","unstructured":"Pishko GL, Muldoon LL, Pagel MA, Schwartz DL, Neuwelt EA (2015) Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis. Fluids Barriers CNS 12:5. doi:\n                    10.1186\/2045-8118-12-5","journal-title":"Fluids Barriers CNS"},{"key":"2000_CR21","doi-asserted-by":"publisher","first-page":"e114311","DOI":"10.1371\/journal.pone.0114311","volume":"9","author":"HL Liu","year":"2014","unstructured":"Liu HL, Huang CY, Chen JY, Wang HY, Chen PY, Wei KC (2014) Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood\u2013brain barrier opening for enhanced temozolomide delivery in glioma treatment. PLoS ONE 9:e114311","journal-title":"PLoS ONE"},{"key":"2000_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.actbio.2014.12.026","volume":"15","author":"CH Fan","year":"2015","unstructured":"Fan CH, Ting CY, Chang YC, Wei KC, Liu HL, Yeh CK (2015) Drug-loaded bubbles with matched focused ultrasound excitation for concurrent blood\u2013brain barrier opening and brain-tumor drug delivery. Acta Biomater 15:89\u2013101","journal-title":"Acta Biomater"},{"key":"2000_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.nano.2013.07.003","volume":"10","author":"GM Bernal","year":"2014","unstructured":"Bernal GM, LaRiviere MJ, Mansour N, Pytel P, Cahill KE, Voce DJ, Kang S, Spretz R, Welp U, Noriega SE, Nunez L, Larsen G, Weichselbaum RR, Yamini B (2014) Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. Nanomedicine 10:149\u2013157","journal-title":"Nanomedicine"},{"key":"2000_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11060-014-1421-6","volume":"118","author":"S Joshi","year":"2014","unstructured":"Joshi S, Singh-Moon RP, Wang M, Chaudhuri DB, Holcomb M, Straubinger NL, Bruce JN, Bigio IJ, Straubinger RM (2014) Transient cerebral hypoperfusion assisted intraarterial cationic liposome delivery to brain tissue. J Neurooncol 118:73\u201382","journal-title":"J Neurooncol"},{"key":"2000_CR25","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1093\/neuonc\/nop054","volume":"12","author":"S Kunwar","year":"2010","unstructured":"Kunwar S, Chang S, Westphal M, Vogelbaum M, Sampson J, Barnett G, Shaffrey M, Ram Z, Piepmeier J, Prados M, Croteau D, Pedain C, Leland P, Husain SR, Joshi BH, Puri RK (2010) Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma. Neuro Oncol 12:871\u2013881","journal-title":"Neuro Oncol"},{"key":"2000_CR26","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/B978-0-444-53502-3.00031-8","volume":"105","author":"HB Newton","year":"2012","unstructured":"Newton HB (2012) Neurological complications of chemotherapy to the central nervous system. Handb Clin Neurol 105:903\u2013916","journal-title":"Handb Clin Neurol"},{"key":"2000_CR27","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/B978-0-7020-4088-7.00080-8","volume":"121","author":"R Soffietti","year":"2014","unstructured":"Soffietti R, Trevisan E, Rud\u00e0 R (2014) Neurologic complications of chemotherapy and other newer and experimental approaches. Handb Clin Neurol 121:1199\u20131218","journal-title":"Handb Clin Neurol"},{"key":"2000_CR28","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1158\/1078-0432.CCR-14-0084","volume":"20","author":"F Lin","year":"2014","unstructured":"Lin F, de Gooijer MC, Roig EM, Buil LC, Christnerm SM, Beumer JH, W\u00fcrdinger T, Beijnen JH, van Tellingen O (2014) ABCB1, ABCG2, and PTEN determine the response of glioblastoma to temozolomide and ABT-888 therapy. Clin Cancer Res 20:2703\u20132713","journal-title":"Clin Cancer Res"},{"key":"2000_CR29","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1158\/1078-0432.CCR-13-2140","volume":"20","author":"M Candolfi","year":"2014","unstructured":"Candolfi M, Yagiz K, Wibowo M, Ahlzadeh GE, Puntel M, Ghiasi H, Kamran N, Paran C, Lowenstein PR, Castro MG (2014) Temozolomide does not impair gene therapy-mediated antitumor immunity in syngeneic brain tumor models. Clin Cancer Res 20:1555\u20131565","journal-title":"Clin Cancer Res"},{"key":"2000_CR30","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.nec.2012.01.008","volume":"23","author":"BJ Shin","year":"2012","unstructured":"Shin BJ, Burkhardt JK, Riina HA, Boockvar JA (2012) Superselective intra-arterial cerebral infusion of novel agents after blood\u2013brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series. Neurosurg Clin N Am 23:323\u2013329","journal-title":"Neurosurg Clin N Am"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-2000-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-015-2000-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-2000-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-015-2000-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T07:19:56Z","timestamp":1589699996000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-015-2000-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,2]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["2000"],"URL":"https:\/\/doi.org\/10.1007\/s11060-015-2000-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,2]]},"assertion":[{"value":"12 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}